Showing results (191-200 of 246) with videos related to

Sort By:
Pageof 25
Nature Cell Biology|September 7, 2021
An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancerAlastair Davies, Shaghayegh Nouruzi, Dwaipayan Ganguli, et al.
Nature Communications|June 19, 2026
Recurrent intra-tumour heterogeneity is a hallmark of metastatic prostate cancerSirui Weng, Lachlan Cain, James Comben, et al.
Nature Communications|October 14, 2025
Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panelsKyle T Helzer, Marina N Sharifi, Jamie M Sperger, et al.
European Urology Oncology|July 12, 2025
Efficacy of Anti-PD-(L)1 Immunotherapy in Patients with DNA Mismatch Repair-deficient Metastatic Castration-resistant Prostate CancerSandra van Wilpe, Tarek Taha, Emily C Rothmann, et al.
European Urology Open Science|August 2, 2021
Combined Longitudinal Clinical and Autopsy Phenomic Assessment in Lethal Metastatic Prostate Cancer: Recommendations for Advancing Precision MedicineJuho Jasu, Teemu Tolonen, Emmanuel S Antonarakis, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2025
Comparative transcriptomics reveals a mixed basal, club, and hillock epithelial cell identity in castration-resistant prostate cancerSamuel P Pitzen, Amber N Rudenick, Yinjie Qiu, et al.
Nature Communications|May 28, 2025
BH3 mimetics targeting BCL-XL have efficacy in solid tumors with RB1 loss and replication stressAndreas Varkaris, Keshan Wang, Mannan Nouri, et al.
Nature Communications|June 21, 2018
Patient derived organoids to model rare prostate cancer phenotypesLoredana Puca, Rohan Bareja, Davide Prandi, et al.
JCO Precision Oncology|January 16, 2018
Next-Generation Rapid Autopsies Enable Tumor Evolution Tracking and Generation of Preclinical ModelsDavid J Pisapia, Steven Salvatore, Chantal Pauli, et al.
Pageof 25